✦ LIBER ✦

A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours

✍ Scribed by Miguel Angel Izquierdo; Margarita García; José Luis Pontón; Marisa Martínez; Vicente Valentí; Matilde Navarro; Miguel Gil; Felipe Cardenal; Ricard Mesía; Xavier Pérez; Ramón Salazar; Josep Ramón Germà-Lluch

Book ID: 116428816
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 142 KB
Volume: 42
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2005.10.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I safety and pharmacokinetic study

Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours

✍ M.J.A. de Jonge; H. Dumez; J.J.E.M. Kitzen; B. Beuselinck; J. Verweij; R. Courtn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Phase I pharmacokinetic and sequence fin

Phase I pharmacokinetic and sequence finding study of the combination of docetaxel and methotrexate in patients with solid tumours

✍ M Louwerens; C Smorenburg; A Sparreboom; W.J Loos; J Verweij; R de Wit 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Phase I clinical and pharmacokinetic stu

Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin/docetaxel or carboplatin/paclitaxel in patients with advanced solid tumors

✍ Bahleda, Rastislav; Sessa, Cristiana; Del Conte, Gianluca; Gianni, Luca; Capri, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 846 KB

Phase I clinical trial of weekly combine

Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors

✍ Jacob Lokich 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A Phase I and feasibility study of combined docetaxel (D) plus paclitaxel (P) was undertaken to determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) for each analogue delivered concomitantly on a weekly schedule. ## METHODS. Patients were accrued in 3-6 patient cohorts to P

Novel paclitaxel formulations for oral a

Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours

✍ S. A. Veltkamp; H. Rosing; A. D. R. Huitema; M. R. Fetell; A. Nol; J. H. Beijnen 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 367 KB

Phase I study on docetaxel and ifosfamid

Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours

✍ Pronk, LC; Schrijvers, D; Schellens, JHM; de Bruijn, EA; Planting, ASTh; Locci-T 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 1014 KB